The impact of COVID-19 on population-level drug utilization of alendronate

Tan EH., Robinson D., Jödicke A., Mosseveld M., Nielsen K., Reyes C., Voss A., Marconi E., Lapi F., Reinold J., Pedersen L., Verhamme K., De Wilde M., Far M., Aragón M., Bosco-Levy P., Lassalle R., Prieto Alhambra D.

DOI

10.1007/s00198-021-06125-9

Type

Conference paper

Publisher

Springer

Publication Date

2022-02-16T00:00:00+00:00

Volume

32

Pages

314 - 315

Total pages

1

Permalink More information Close